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ABSTRACT  
Introduction  
The emergence of the novel respiratory SARS-CoV-2 and subsequent COVID-19 pandemic has 
required rapid assimilation of population-level data to understand and control the spread of 
infection in the general and vulnerable populations.  Rapid analyses are needed to inform 
policy development and target interventions to at risk groups to prevent serious health 
outcomes. We aim to provide an accessible research platform to determine demographic, 
socioeconomic and clinical risk factors for infection, morbidity, and mortality of COVID-19, to 
measure the impact of COVID-19 on healthcare utilisation and long-term health, and to 
enable the evaluation of natural experiments of policy interventions.  
 
Methods and analysis  
Two privacy-protecting population-level cohorts have been created and derived from multi-
sourced demographic and healthcare data. The C20 cohort consists of 3.2 million people in 
Wales on the 1st January 2020 with follow up until 31st May 2020. The complete cohort 
dataset will be updated monthly with some individual datasets available daily. The C16 cohort 
consists of 3 million people in Wales on the 1st January 2016 with follow up to the 31st 
December 2019. C16 is designed as a counterfactual cohort to provide contextual 
comparative population data on disease, health service utilisation, and mortality. Study 
outcomes will: a) characterise the epidemiology of COVID-19, b) assess socioeconomic and 
demographic influences on infection and outcomes, c) measure impact of COVID-19 on short 
term and longer-term population outcomes and d) undertake studies on the transmission and 
spatial spread of infection.  
 
Ethics and dissemination  
The Secure Anonymised Information Linkage (SAIL) independent Information Governance 
Review Panel (IGPR) has approved this study.  The study findings will be presented to policy 
groups, public meetings, national and international conferences, and published in in peer-
reviewed journals.  
 
 
 
Strengths and limitations of this study 
• Rapid access to multiple data sources on a complete population.  
• Great variety of individual and household level data on demography, disease status, 
morbidity, mortality and viral genomics to support a wide range of studies on the 
evolution of the epidemic in Wales.   
• Ability to support hierarchical analyses at varying geographical units: private 
residences, care homes, educational setting and healthcare facilities to examine 
spatial spread and transmission of SARS-CoV-2 to inform and evaluate targeting of 
interventions.  
• However, routine data does not capture data on some important aspects, such as 
quality of life 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
Understanding and controlling the COVID-19 pandemic is a rapidly changing, complex issue 
that requires near real-time local data, analyses, modelling and multidisciplinary team science 
to devise, implement and evaluate a wide variety of inter- and cross-sectoral interventions to 
minimise population harm.[1] 
 
As the pandemic evolves a wide range of issues need to be considered including: the spread 
of infection in the general and vulnerable populations; health service resilience; indirect harm 
minimisation; and effectiveness of control policies and interventions. 
 
Responding to this challenge, the Welsh Government created a COVID-19 Technical Advisory 
Group (TAG) to provide rapid assimilation of available evidence and guide analysis of data to 
inform policy development and appraisal. Insight from linked data is seen as being essential 
to understand the evolving epidemic. TAG commissioned the support of analyses conducted 
through the Secure Anonymised Information Linkage (SAIL) Databank 
(www.saildatabank.com) to formulate evidence and advice to underpin its work in responding 
to COVID-19.[2-5] SAIL is a state of the art, remotely accessible, privacy-protecting system, 
accredited under the Digital Economy Act. SAIL holds and provides access to linked de-
identified data from multiple sources at individual, household and multiple ecological levels, 
for the population of Wales. The SAIL Databank has previously supported numerous types of 
clinical and population studies, including cohorts, evaluations of natural experiments and 
embedded trials.[6-13] 
 
This paper describes the development of two population-based cohorts in Wales, derived 
from multiple data sources to provide near real-time, in-pandemic intelligence and analytics 
to TAG in relation to the following broad objectives: 
 
Primary objectives 
a) Determine demographic, socioeconomic and clinical risk factors for infection, 
morbidity, and mortality related COVID-19; 
b) Determine risk of COVID-19 infection and outcomes in occupational groups; and 
c) Measure the population impact of COVID-19 on healthcare utilisation. 
 Secondary objectives 
a) Create a platform to enable the evaluation of policies and interventions aimed at 
controlling the epidemic, whether clinical or non-pharmaceutical in nature; and 
b) Provide access to these derived population-based cohorts and linked data sources to 
organisation and people with relevant skills and expertise within the NHS, academia 
and government. 
 
METHODS 
Study design and population 
The cohorts were derived from de-identified linked data from the SAIL Databank. We created 
two population-based cohorts derived from multiple demographic and healthcare data 
sources (Figure 1):  
• The C20 cohort consists of all people alive and known to the National Health Service 
(NHS) in Wales from the 1st January 2020 with follow up until 31st May 2020. We 
include people who moved into or were born in Wales after 1st January 2020. Follow-
up data will be added prospectively and the C20 cohort will be updated on a monthly 
basis in line with a full month of coverage of available data. Linkage to other data 
sources is also available beyond the cohort end date where the frequency and quality 
of each data source allows its use. Some datasets are analysed daily.  
• The C16 cohort includes all individuals living in Wales and known to the NHS on the 1st 
January 2016 with follow up to the 31st December 2019. C16 is designed to provide 
counterfactual and contextual comparative data on population health service 
utilisation, and mortality rates.  
Membership of both cohorts is based on the inclusion of a person’s residence in Wales, 
registered to a Welsh General Practice, a free to use NHS system at the point of primary care 
registration in the UK (Figure 2). This is recorded within the Wales Demographic Service 
Dataset (WDSD). People are censored by study endpoint or migration out of Wales. 
 
Data Sources 
Baseline populations are created using the weekly updated WDSD, the monthly updated 
Office for National Statistics (ONS) mortality registry data known as the Annual District Death 
Extract (ADDE), two new COVID-19 daily data sources: the Consolidated Death Data Source 
(CDDS) created by NHS Wales Informatics Service (NWIS), and the Annual District Death Daily 
(ADDD) from ONS. 
 
Anonymised Linkage Fields 
Linkage fields are used to anonymously link between data sources in the SAIL Databank. SAIL 
utilises a multiple encryption system in which a trusted third party, the NHS Wales Informatics 
Service, uniquely matches identities to an Anonymised Linkage Field (ALF) and residences to 
a Residential Anonymised Linkage Field before uploading data to SAIL.[2,3,14] 
 
Demographic data 
The cohorts include the following variables: Anonymised Linkage Field (ALF), age, sex, date of 
death, date of movement out of Wales, Residential Anonymised Linkage Field (RALF) and Care 
Home Anonymised Linkage Fields (CHALFs) for older people at cohort inception. The CHALF 
was derived from a data extract from Care Inspectorate Wales in 2020 for all adult care home 
settings.[8] Geographical variables associated with the RALF and CHALF include Lower Layer 
Super Output Area (LSOA) 2011 boundaries which are small statistical areas containing 
around 1500 people. LSOA 2011 has been mapped to the Welsh Index of Multiple Deprivation 
(WIMD) version 2019 to derive deprivation quintiles; Welsh health board of residence; and 
urban/rurality categories.[15,16] Using Welsh Government’s Pupil Level annual school census 
(PLASC), the school population can also be linked to the cohorts for analyses by school 
network.[17] 
 
In addition, permission has been granted to embed occupation and role categories from 
electronic staff records of all NHS health boards and trusts, local authority social care workers 
and education staff. For healthcare workers, the electronic staff records system used in all 
health boards and trusts (111,000) are categorised by whether roles involve direct patient 
care or not and by occupational groups: Additional Professional Scientific and Technical; 
Additional Clinical Service; Administrative and Clerical; Allied Health Professionals; Estates 
and Ancillary; Healthcare Scientist; Medical and Dental, Nursing and Midwifery Registered; 
and Students. Social care workers are registered (https://socialcare.wales/) and grouped into 
social workers, child home workers and domiciliary care workers (estimated 32,000). 
Educational staff records (estimated 70,000) include categories for teachers, support and 
administrative staff. This information is collected from the annual School Workforce Annual 
Census (SWAC) held by Welsh Government.[18] Data on care home staff is collected as part 
of Public Health Wales testing of all staff and residents and made available in SAIL through 
the standard Laboratory Information Management System (LIMS) dataset. Permission has 
also been granted to link 2011 ONS census fields on ethnicity, occupation, housing tenure, 
over-crowding and socio-economic status. Ethnicity codes are derived from multiple health 
and social data sources mapped to Census 2011 groupings.[19] 
 
Health data 
All hospital admissions, outpatient and emergency department attendances treated in NHS 
hospitals as well as GP data on all diagnoses and treatments from SAIL providing practices 
(80% population coverage) are available for cohort participants.[20] As of the beginning of 
2020, we have added: 
• Daily GP respiratory and COVID codes for 100% of Welsh GP practices.  
• Daily COVID-19 antigen test results. 
• Bi-weekly data on participants reporting symptoms through the KCL/ZOE symptom 
tracking app. [21] 
• Weekly critical care data from the Intensive Care National Audit and Research Centre 
(ICNARC). [22-23] 
• Bi-weekly COVID-19 viral genomic variant call format (VCF) data and viral lineage 
assignments from Public Health Wales (PHW).[24] 
• Monthly community dispensing data from pharmacies providing NHS issued 
prescriptions, backdated to 2016.[25] 
Exposure variables and potential confounding factors 
A number of exposure variables will be used to contextualise the study primary outcomes, 
including age, sex, socioeconomic status (SES) and clinical risk groups. 
 
Socio-economic status (SES) will be derived from WIMD with quintile 1 including the 20% most 
deprived areas, and also at individual/household level from 2011 census using the following 
codes: approximated social grade (SCGPUK11); highest level of qualification (HLQPUK11), and 
National Statistics Socio-economic Classification (NSSEC).[26] 
 
Clinical risk groups have been derived from those used in scientific papers:   
• Predictors of influenza and COVID-19 outcomes.[27-28]  
• Published phenotype (disease conditions) libraries including the 308 phenotypes 
created by the CALIBER study.[29]  
• Commonly used comorbidity indices (Charlson and Elixhauser).[30-31]  
• Frailty indices (electronic Frailty Index for GP data and Hospital Frailty Risk Score).[32-
34]  
In order to compare and combine results with other studies we will replicate the 19 clinical 
groups included in a similar study in Scotland.[35] 
 
Microbiological testing data will be de-duplicated and used to generate case-data for 
standard case definitions, agreed at UK level where possible. 
 
Body mass index (BMI) will be categorised as < 20, 20-24, 25-29, 30-39, ≥ 40 kg/m2; and 
smoking status categorised into four groups: current smoker, non-smoker, ex-smoker and not 
recorded for patients with no data on smoking, replicated from a study carried out in 
Scotland.[35]  
 
Statistical analysis 
We will describe baseline characteristics for exposures and outcomes of interest utilising 
means, medians, proportions, odds ratios (ORs) and rate ratios (RRs) with appropriate 
measures of dispersion. We will report on prevalence of missing data by variable and utilise 
two tailed hypothesis tests with 5% significance level.  
 
Non-independence of observations measured over time or within associated clusters, e.g. 
General Practice or households will be taken into account using random effects. We will use 
causal frameworks where causal relationships are implied.[36] Hypotheses being tested will 
be stated in advance and plans will be drawn up for each research project. Analyses will 
primarily be conducted in R statistical programming language.[37-38] 
 
Analyses 
We will test associations for demographic, socioeconomic, and clinical risk factors for COVID-
19 infection and associated morbidity and mortality. COVID-19 infection will be defined in a 
number of ways: a) positive SARS-CoV-2 laboratory antigen test, b) clinical diagnosis of COVID-
19 infection in GP records, intensive care, or hospital discharge records, c) ONS mortality 
records listing COVID19 as the underlying or contributory cause, and d) positive serology 
report (when available).  
Planned analyses include:  
• Incidence of COVID-19 over time and by geography and demographic groups.  
• Influence of area deprivation and individual SES metrics on infection and outcomes. 
• Impact of COVID-19 on short term (<6 months) and longer-term population 
outcomes such as changes in health service utilisation and excess, overall and 
disease-specific mortality. 
• Description of the extent of clustering of cases within all available residential, 
educational, occupational, and geographic units, thus providing signatures of spatial 
spread at defined levels, and between levels, thought to have played a crucial role in 
transmission.  
We will investigate the relationship between health (physical and mental), socioeconomic, 
and environmental factors, such as self-rated health, limiting long-term illness, housing 
tenure, over-crowding, education status, and occupation on infection risk and outcome.  
Changes in healthcare utilisation will be assessed by measuring differences pre and post-
infection for: NHS111 telephone calls, GP consultations, emergency department attendances, 
hospital admissions and length of stay, and intensive care admissions. 
 
Analytical techniques will include descriptive statistics, univariate and multivariate 
generalised linear mixed models, survival analyses, and the use of self-controlled case series 
for temporary risk factors.[39] Relationships between variables will be clarified before specific 
analyses.  
 
Cohort Characteristics 
The C16 and C20 cohorts have been constructed from patients registered with all General 
Practice in Wales (Table 1).  
 
Table 1: C16 and C20 cohort demographics to end May 2020. 
Cohort C16  C20 
Individuals (N) 3,087,032 3,277,114 
Cohort start date 2016-01-01 2020-01-01 
Cohort end date 2019-12-31 2020-05-31 
Deaths in period  117,565 (3.8%) 16,380 (0.5%) 
Full coverage (cohort end 
date = 2019-12-31/2020-05-
31) 
2,651,957 
(85.9%) 
3,237,389 
(98.8%) 
Registered with a SAIL 
providing practice 
(registration end date > 
cohort start date)   
2,608,761 
(84.5%) 
2,666,331 
(81.4%) 
Mean age (sd) 41.3 (23.7) 41.9 (23.8) 
Sex   
Female 50.1% 50.1% 
*WIMD 2019 Quintile   
1 20.3% 19.1% 
2 19.9% 18.5% 
3 20.1% 18.4% 
4 19.7% 18.1% 
5 19.9% 18.3% 
Missing WIMD 0.0% 7.7% 
*WIMD 2019 Quintile: 1 = most deprived, 5 = least deprived, please 
note a one decimal place rounding error. 
 
Power to detect relevant outcomes will be assessed as the pandemic evolves. There are plans 
to collaborate with researchers across the UK and collating data from similar cohorts,[35] to 
maximise power, support the evaluation of natural experiments in policy and its timing 
around disease control and exit strategies from the lockdown on physical restrictions that 
commenced on March 23rd 2020. 
 
The individual datasets that comprise the cohorts are held on the globally accessible SAIL 
databank available to accredited researchers.  
 
Proposed future developments 
As the pandemic evolves so will policies and practices to control the epidemic and mitigate 
negative consequences. As these develop, we plan to utilise the cohorts as a platform for their 
evaluation, by linking dates and presence of interventions as data become available. There 
are subtle differences in the timing and approaches to controlling the epidemic in diverse 
settings and in exiting lockdown across the four UK nations. This provides opportunities for 
collaborative and timely evaluation of natural experiments of policies and approaches across 
the UK, which would refine evidence-based exit strategies. We are also keen to contribute to 
international initiatives.  
 
 
Patient and public involvement 
This study is based on an extension of the developing Wales Multi-morbidity Cohort (WMC). 
CD and JD are members of the public were involved in the design of the WMC and C20/C16 
studies.  Additional members of the public are in the process of being recruited to the 
research steering committee to represent the views of health, social care and educational 
staff. 
 
Ethics and dissemination 
SAIL’s independent Information Governance Review Panel (IGRP),[5] has approved a 
submission to allow the use of WMC with additional data flows to aid the COVID-19 research 
response (SAIL project 0911). IGRP applications are scrutinised by members of the public; only 
those applications that can demonstrate privacy protection and are in the public interest are 
approved. SAIL’s Consumer Panel, comprising members of the public, were consulted during 
the development of WMC. Two members of the public were recruited to the study steering 
group following approval. 
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Figure 1. Data linkage of multiple demographic and healthcare data sources used in the creation of two population wide cohorts C20 and C16 
 
Figure 2. CONSORT diagram of the C20 cohort inclusion criteria 
 
